ARTICLEBeta-Blockers: Off-Label Use in Psychiatric DisordersNewman, William J. MD; Xiong, Glen L. MD; Barnhorst, Amy V. MDSection Editor(s): Janicak, Philip G. MD; Editor Author Information Dr. Newman is Assistant Professor of Psychiatry and Associate Training Director of the Forensic Psychiatry Fellowship Program, Department of Psychiatry and Behavioral Sciences; Dr. Xiong is Medical Director of the Sacramento County Mental Health Treatment Center and Associate Professor of Psychiatry; and Dr. Barnhorst is Assistant Professor of Psychiatry, University of California-Davis School of Medicine, Division of Psychiatry and the Law, University of California-Davis Medical Center, 2230 Stockton Boulevard, 2nd Floor, Sacramento, CA 95817; E-mail: email@example.com. All faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations related to this CME activity. The authors have disclosed that the use of beta-beta blockers such as propranolol, pindolol, atenolol, and metoprolol for psychiatric disorders as discussed in this article has not been approved by the U.S. Food and Drug Administration. Please consult the product labeling for approved uses. Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article(s) and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 80% of the quiz questions correctly. This activity expires on September 30, 2014. Psychopharm Review: October 2013 - Volume 48 - Issue 10 - p 73-80 doi: 10.1097/01.PSYPHR.0000436763.15959.dc Buy Take the CME Test Metrics © 2013 by Lippincott Williams & Wilkins, Inc.